Berlin, October 21, 2014. This year’s Eckert & Ziegler Abstract Award went to five nuclear medicine specialists from Australia, the United Kingdom, Germany, Italy and Canada at the congress of the European Association of Nuclear Medicine (EANM) in Gothenburg. The prizes were awarded for research work in the fields of cancer diagnostics and therapy.
The competition, which is run by Eckert & Ziegler AG in cooperation with the EANM and awards prizes of €1,000 each, was held for the seventh time.
“Radiodiagnostics play a key role in personalized medicine, which allows patients to receive customized therapy thanks to advance diagnosis. A special test during diagnosis makes it possible to determine before treatment whether a drug is likely to have the desired effect on a patient. With our Abstract Award, we hope to make a contribution to researching and expanding the spectrum of indications for personalized diagnosis and therapy,” explained Dr. André Heß, Member of the Executive Board of Eckert & Ziegler AG and Head of the Radiopharma Segment.
The purpose of the Eckert & Ziegler Abstract Award is to help young research scientists present their work on medical imaging to a wide audience.
More information on the Eckert & Ziegler Abstract Award is available here.
About Eckert & Ziegler
Eckert & Ziegler Strahlen- und Medizintechnik AG (ISIN DE0005659700) is one of the world’s largest providers of isotope technology for radiation therapy and nuclear medicine and has more than 700 employees worldwide.
Contributing to saving lives
If you have any questions, please contact:
Eckert & Ziegler AG
Karolin Riehle, Investor Relations & PR, Robert-Rössle-Str. 10, 13125 Berlin, Germany
Tel.: +49 (0) 30 / 941084-138, Fax-112, E-Mail: karolin.riehle@ezag.de, www.ezag.de
